NBRV News and Press, Nabriva Therapeutics plc From 11/07/22

DUBLIN, Ireland and FORT WASHINGTON, Pa., Nov. 07, 2022 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, today announced that it will rep...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: Shutterstock Rigetti (NASDAQ: RGTI ) stock is getting a boost on Friday after the company revealed it found new partners for its quantum computing efforts. First up is a partnership with Bluefors . ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: NYCStock / Shutterstock.com Esports Entertainment (NASDAQ: GMBL ) stock is falling hard on Friday after the company revealed public stock offering details . The latest press release has Esports Entert...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: iQoncept / Shutterstock Nabriva Therapeutics (NASDAQ: NBRV ) stock caught the attention of traders on Friday after shares surged in price this morning. However, not all is as it seems. While shares of ...

InvestorPlace - Stock Market News, Stock Advice & Trading Tips Source: f11photo/Shutterstock.com We’re starting off the final trading day of the week with a look at the biggest pre-market stock movers for Friday! Moving shares this morning are reverse stock splits, an as...

3 Penny Stocks to Add to Your Watchlist Today When it comes to trading penny stocks, there are a lot of aspects that go into it. You need to have a firm understanding of the market, what penny stocks are worth investing in, and how to make money off of them. However, if you’r...

Biopharmaceutical company Nabriva Therapeutics ( NASDAQ: NBRV ) is set to effect a 1-for-25 reverse stock split, effective for trading purposes on the Nasdaq Capital Market as of Sep. 16. The company's shareholders approved the stock split at the annual general meeting of ...

DUBLIN, Ireland and FORT WASHINGTON, Pa., Sept. 15, 2022 (GLOBE NEWSWIRE) --  Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, today announced that it w...

DUBLIN, Ireland and FORT WASHINGTON, Pa., Sept. 06, 2022 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, today announced that Ted Schroe...

DUBLIN, Ireland and FORT WASHINGTON, Pa., Aug. 11, 2022 (GLOBE NEWSWIRE) -- Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical company engaged in the commercialization and development of innovative anti-infective agents to treat serious infections, announced the completion of pati...